Rituximab monotherapy following surgical resection of gastrointestinal post-transplant lymphoproliferative disorder in solid organ transplant recipients

Clin Transplant. 2023 Feb;37(2):e14910. doi: 10.1111/ctr.14910. Epub 2023 Jan 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal
  • Epstein-Barr Virus Infections*
  • Humans
  • Lymphoproliferative Disorders* / drug therapy
  • Lymphoproliferative Disorders* / etiology
  • Organ Transplantation* / adverse effects
  • Rituximab / therapeutic use
  • Transplant Recipients

Substances

  • Rituximab
  • Antibodies, Monoclonal